BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han Y, Qu YQ, Mok SWF, Chen J, Xia CL, He HQ, Li Z, Zhang W, Qiu CL, Liu L, Law BYK, Wong VKW. A Novel Drug Resistance Mechanism: Genetic Loss of Xeroderma Pigmentosum Complementation Group C (XPC) Enhances Glycolysis-Mediated Drug Resistance in DLD-1 Colon Cancer Cells. Front Pharmacol 2019;10:912. [PMID: 31551763 DOI: 10.3389/fphar.2019.00912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin Q, Luo L, Wang H. A New Oxaliplatin Resistance-Related Gene Signature With Strong Predicting Ability in Colon Cancer Identified by Comprehensive Profiling. Front Oncol 2021;11:644956. [PMID: 34026619 DOI: 10.3389/fonc.2021.644956] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bhoi P, Thorat SG, Alasmary FA, Wabaidur SM, Islam MA. Design, synthesis, molecular modelling and antiproliferative evaluation of novel benzothiazole trihybrids. Biophys Chem 2021;278:106664. [PMID: 34438243 DOI: 10.1016/j.bpc.2021.106664] [Reference Citation Analysis]
3 Khan AQ, Rashid K, Alamodi AA, Raza SS, Uddin S. Recent developments in unraveling signaling mechanisms underlying drug resistance due to cancer stem-like cells. Current Opinion in Pharmacology 2020;54:130-41. [DOI: 10.1016/j.coph.2020.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]